Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Double-Blind Placebo Controlled Study of Oral Pomella on the Microbiome and Skin Biophysical Properties

NCT04596722 is registered in ClinicalTrials.gov with Integrative Skin Science and Research as lead sponsor.

NCT NCT04596722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04596722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Double-Blind Placebo Controlled Study of Oral Pomella on the Microbiome and Skin Biophysical Properties
Lead sponsor
Integrative Skin Science and Research
Phase
Not applicable
Overall status
Completed
Start date
November 9, 2020
Completion date
March 24, 2021
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human microbiome